Study of SYN023 for children exposed to rabies
Part of Infections clinical trials.
This study looks at how well the rabies treatment SYN023 works in children under 18 who have had a high-risk (Category III) animal bite. It tests a combination of medications given right after the bite to prevent rabies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 18 years old
- You had a high-risk rabies exposure (like a bite from a dog or other animal) within the last 7 days
- You have already started treatment with wound care, rabies shots, and the study medicine within the past 24 hours
- Your parent or guardian agrees to the study and you agree if you are 8 or older
- You can complete all study visits, including rabies shots and follow-up for one year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new RSV vaccine called YKYY025 in healthy adults. The main goal is to see if it is safe and to measure how the immune system responds.
This trial tests a rabies vaccine to see if it works well and is safe when given after a potential rabies exposure. It may help people who need protection after an animal bite.
This program provides access to an experimental rabies treatment called SYN023 for people who cannot get other treatments. It might help if standard options are not available or suitable for you.
This trial tests a new rabies vaccine to see how well it works and if it is safe for people who have not been exposed to rabies. It may be a good option if you want protection before potential exposure.
This trial checks how well a rabies booster shot works in healthy adults who had rabies pre-exposure shots at least 5 years ago. It compares three different booster schedules to see which one best protects against rabies.
This study tests how well a rabies vaccine works and how safe it is for people whose immune systems may be weaker, such as those with certain long-term illnesses, organ transplants, or age 60 and older. It compares them to healthy adults ages 18 to 59.
Hear when a new Rabies Post-exposure Prophylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.